Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

The immunogenicity of the candidate tuberculosis (TB) vaccine MVA85A may be enhanced by aerosol delivery. Intradermal administration was shown to be safe in adults with latent TB infection (LTBI), but data are lacking for aerosol-delivered candidate TB vaccines in this population. We carried out a P...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Riste, M, Marshall, JL, Satti, I, Harris, SA, Wilkie, M, Lopez Ramon, R, Wright, D, Wittenberg, RE, Vermaak, S, Powell Doherty, R, Lawrie, A, Conlon, CP, Cosgrove, C, Gleeson, F, Lipman, M, Moss, P, Perrin, F, Dedicoat, M, Bettinson, H, McShane, H
বিন্যাস:	Journal article
ভাষা:	English
প্রকাশিত:	MDPI 2021

অনুরূপ উপাদানগুলি

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <em>M.tb</em>-Infected Adults
অনুযায়ী: Michael Riste, অন্যান্য
প্রকাশিত: (2021-04-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
অনুযায়ী: Thomas, Z, অন্যান্য
প্রকাশিত: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
অনুযায়ী: Tameris, M, অন্যান্য
প্রকাশিত: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
অনুযায়ী: Tameris, M, অন্যান্য
প্রকাশিত: (2014)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
অনুযায়ী: Mcshane, H
প্রকাশিত: (2008)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial
অনুযায়ী: Manjaly Thomas, Z, অন্যান্য
প্রকাশিত: (2019)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
অনুযায়ী: Rowland, R, অন্যান্য
প্রকাশিত: (2012)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
অনুযায়ী: Michele Tameris, অন্যান্য
প্রকাশিত: (2014-01-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
অনুযায়ী: Harris, S, অন্যান্য
প্রকাশিত: (2011)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
অনুযায়ী: Meyer, J, অন্যান্য
প্রকাশিত: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
অনুযায়ী: Meyer, J, অন্যান্য
প্রকাশিত: (2013)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
অনুযায়ী: Zita-Rose Manjaly Thomas, অন্যান্য
প্রকাশিত: (2019-04-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
অনুযায়ী: Anne Wajja, অন্যান্য
প্রকাশিত: (2017-05-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
অনুযায়ী: Wajja, A, অন্যান্য
প্রকাশিত: (2017)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
অনুযায়ী: Sander, C, অন্যান্য
প্রকাশিত: (2005)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
অনুযায়ী: Minassian, A, অন্যান্য
প্রকাশিত: (2011)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
অনুযায়ী: Harris, S, অন্যান্য
প্রকাশিত: (2013)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
অনুযায়ী: Odutola, A, অন্যান্য
প্রকাশিত: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
অনুযায়ী: Odutola, A, অন্যান্য
প্রকাশিত: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
অনুযায়ী: Dieye, T, অন্যান্য
প্রকাশিত: (2013)

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
অনুযায়ী: Wilkie, M, অন্যান্য
প্রকাশিত: (2019)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
অনুযায়ী: Whelan, K, অন্যান্য
প্রকাশিত: (2009)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
অনুযায়ী: Pathan, A, অন্যান্য
প্রকাশিত: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
অনুযায়ী: Pathan, A, অন্যান্য
প্রকাশিত: (2012)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
অনুযায়ী: Owiafe, P, অন্যান্য
প্রকাশিত: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
অনুযায়ী: Tandakha N Dieye, অন্যান্য
প্রকাশিত: (2013-01-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
অনুযায়ী: Kathryn T. Whelan, অন্যান্য
প্রকাশিত: (2011-01-01)

TB vaccine development: where are we and why is it so difficult?
অনুযায়ী: Wilkie, M, অন্যান্য
প্রকাশিত: (2014)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
অনুযায়ী: Tandakha N. Dieye, অন্যান্য
প্রকাশিত: (2013-01-01)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
অনুযায়ী: Minhinnick, A, অন্যান্য
প্রকাশিত: (2016)

Diagnosis of extrapulmonary TB: Experience with the Xpert MTB/Rif assay
অনুযায়ী: C.N. Govind, অন্যান্য
প্রকাশিত: (2014-04-01)

Evaluation of Xpert MTB/RIF assay for the diagnosis of paediatric TB
অনুযায়ী: F. Ismail, অন্যান্য
প্রকাশিত: (2014-04-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
প্রকাশিত: (2011-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
অনুযায়ী: Raksha Rimal, অন্যান্য
প্রকাশিত: (2022-04-01)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
অনুযায়ী: Giovana Rodrigues Pereira, অন্যান্য
প্রকাশিত: (2018-01-01)

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
অনুযায়ী: Neeraj Raizada, অন্যান্য
প্রকাশিত: (2014-01-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
অনুযায়ী: Mcshane, H, অন্যান্য
প্রকাশিত: (2016)

TB or not TB?
অনুযায়ী: Andrew Pirotte, অন্যান্য
প্রকাশিত: (2024-04-01)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
অনুযায়ী: Satti, I, অন্যান্য
প্রকাশিত: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
অনুযায়ী: Satti, I, অন্যান্য
প্রকাশিত: (2014)